Adding toripalimab (Loqtorzi) to chemo extended survival in people with nasopharyngeal cancer that returned after initial treatment or spread in the body.
FDA Approves Toripalimab for Advanced Nasopharyngeal Cancer
Posted in biotech/medical
Posted in biotech/medical
Adding toripalimab (Loqtorzi) to chemo extended survival in people with nasopharyngeal cancer that returned after initial treatment or spread in the body.